Causaly
PrivateLast Round
Series B
Jul 13, 2023
Total Funding Raised
$82.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Causaly is a biotechnology company that provides an AI-powered platform for life sciences and pharmaceutical research to accelerate drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, NLP & Conversational AI, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Causaly Comparables
Compare Causaly with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BenchSci | 89% | |
| Epistemic AI | 83% | |
| Biorelate | 80% | |
Causaly Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 13, 2023 | ||||
| Series A Extension | May 19, 2021 | ||||
| Series A | Nov 19, 2019 | ||||
| Seed | Jul 26, 2018 |
Key People
Founding team and executive leadership
Causaly Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ICONIQ Growth | Series B |
| Visionaries Club | Series B |
| Marathon Venture Capital | Series A, Series A Extension, Series B, Seed |
| Emerge | Seed |
| European Bank for Reconstruction and Development | Series A, Series A Extension, Series B |
| Index Ventures | Series B, Series A Extension |
| Pentech | Series A Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 8, 2026
Added L’Oréal Group as a customer.
- Mar 8, 2026
Added Lupin Pharmaceuticals as an enterprise customer.
Causaly Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Causaly's valuation, stock price, and market status.